Carbidopa / Levodopa · Dhivy

What is Carbidopa / Levodopa?

Carbidopa/levodopa is a combination of carbidopa, an aromatic amino acid decarboxylation inhibitor, and levodopa, an aromatic amino acid.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as

Dhivy, CREXONT ER

Drug type

Small molecule

Pathways

aromatic amino acid decarboxylation, dopamine synthesis

Therapy area

Neurology

Developer

Avion Pharms

In trials of

AMRX

FDA status

Approved as Dhivy (November 12, 2021), NDA214869 · FDA label

✅ FDA-approved uses

• Parkinson's disease
• Post-encephalitic parkinsonism
• Symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication

From the indications section of the FDA label (version of Aug 21, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Parkinson Disease

Sources

• FDA label Dhivy (2026-08-21), indications

Updated Oct 11, 2026.